Analisis Kinerja Keuangan Perusahaan Sub Sektor Farmasi yang Terdaftar di Bursa Efek Indonesia Tahun 2019-2021

SUBAGIYO, ASHAR GHANY RAHMAN (2022) Analisis Kinerja Keuangan Perusahaan Sub Sektor Farmasi yang Terdaftar di Bursa Efek Indonesia Tahun 2019-2021. KTTA thesis, Politeknik Keuangan Negara STAN.

	Text (Cover) 01. Cover_Ashar Ghany Rahman Subagiyo_1302190491.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (15kB)
	Text (Abstrak) 02. Abstrak_Ashar Ghany Rahman Subagiyo_1302190491.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (7kB)
	Text (Daftar Isi) 03. Daftar Isi_Ashar Ghany Rahman Subagiyo_1302190491.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (19kB)
	Text (Bab I) 05. Bab I_Ashar Ghany Rahman Subagiyo_1302190491.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (132kB)
	Text (Bab II) 06. Bab II_Ashar Ghany Rahman Subagiyo_1302190491.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (35kB)
	Text (Bab III) 07. Bab III_Ashar Ghany Rahman Subagiyo_1302190491.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (786kB)
	Text (Bab IV) 08. Bab IV_Ashar Ghany Rahman Subagiyo_1302190491.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (7kB)
	Text (Daftar Pustaka) 09. Daftar Pustaka_Ashar Ghany Rahman Subagiyo_1302190491.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (6kB)

Abstract

Penelitian ini bertujuan untuk mengetahui kinerja keuangan di masa pandemi Covid-19 pada PT Kalbe Farma Tbk, PT Kimia Farma Tbk, dan PT Indofarma Tbk berdasarkan analisis rasio keuangan. Variabel yang digunakan yaitu profitabilitas, solvabilitas, likuiditas, dan aktivitas. Analisis dilakukan dengan menggunakan data sekunder berupa laporan keuangan perusahaan dari tahun 2019 sampai tahun 2021 yang berasal dari Bursa Efek Indonesia. Hasil penelitian menunjukkan bahwa PT Kalbe Farma Tbk memiliki kinerja keuangan yang baik pada profitabilitas, solvabilitas, likuiditas, dan aktivitas. Sedangkan untuk PT Kimia Farma Tbk memiliki kinerja keuangan yang baik dalam profitabilitas dan solvabilitas, namun kurang baik dalam likuiditas dan aktivitas. Sementara PT Indofarma Tbk memiliki kinerja keuangan yang cukup baik dalam likuiditas, profitabilitas, dan aktivitas, namun kurang baik dalam solvabilitas./This research aims to determine financial performance at the time of Covid-19 pandemic of PT Kalbe Farma Tbk, PT Kimia Farma Tbk, and PT Indofarma Tbk in 2019-2021 based on financial ratio analysis. The variables used are profitability, solvability, liquidity, and activity. The analysis was conducted by processing secondary data in the form of company financial statements from 2019 until 2021 originating from the Indonesian Stock Exchange. The results of the research show that PT Kalbe Farma Tbk has a good financial performance on profitability, solvability, liquidity, and activity. Meanwhile, PT Kimia Farma Tbk has a good financial performance on profitability and solvability, but not good enough on liquidity and activity. While PT Indofarma Tbk has a good enough financial performance on liquidity, profitability, and activity, but not good enough on solvability.

Actions (login required)

View Item